Drug
Fenfluramine
Fenfluramine: highest development phase Phase 3, developed by UCB. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| fenfluramine NCT06118255 | Phase 3 | Dravet Syndrome |
| fenfluramine hydrochloride NCT07503444 | Phase 3 | Rett Syndrome |
Latest
No recent events.
Follow Fenfluramine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.